NYSEAMERICAN:SENSSenseonics Stock Price, Forecast & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Senseonics in the last year. There are currently 2 sell ratings, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Senseonics.

Senseonics is scheduled to release its next quarterly earnings announcement on Thursday, May 28th 2020. View our earnings forecast for Senseonics.

Senseonics Holdings Inc (NYSEAMERICAN:SENS) announced its quarterly earnings data on Thursday, March, 12th. The company reported ($0.18) EPS for the quarter, missing the Zacks' consensus estimate of ($0.16) by $0.02. The company earned $9 million during the quarter, compared to analysts' expectations of $7.93 million. View Senseonics' earnings history.

Senseonics issued an update on its FY 2020 After-Hours earnings guidance on Thursday, March, 12th. The company provided EPS guidance of for the period. The company issued revenue guidance of $15-20 million, compared to the consensus revenue estimate of $36.29 million.

8 brokers have issued 12-month price objectives for Senseonics' shares. Their forecasts range from $0.25 to $2.00. On average, they anticipate Senseonics' share price to reach $1.23 in the next year. This suggests a possible upside of 145.8% from the stock's current price. View analysts' price targets for Senseonics.

Headlines about SENS stock have trended somewhat positive this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Senseonics earned a media sentiment score of 1.6 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutSenseonics.

Some companies that are related to Senseonics include Volpara Health Tech (VHT), Profound Medical (PRN), Renalytix Ai (RENX), Akumin (AKU), Exagen (XGN), Yourgene Health (YGEN), Palatin Technologies (PTN), MaxCyte (MXCT), Oncosil Medical (OSL), Lexagene (LXG), Oncimmune (ONC), Genedrive (GDR), SQI Diagnostics (SQD), BARD1 Life Sciences (BD1) and Sernova (SVA). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Senseonics investors own include Advanced Micro Devices (AMD), Agile Therapeutics (AGRX), Amarin (AMRN), Crispr Therapeutics (CRSP), Sorrento Therapeutics (SRNE), Tandem Diabetes Care (TNDM), VirnetX (VHC), Micron Technology (MU), Nabriva Therapeutics (NBRV) and Protalix Biotherapeutics (PLX).

Senseonics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "SENS."

Senseonics' stock is owned by a number of institutional and retail investors. Top institutional investors include NEA Management Company LLC (13.71%), BlackRock Inc. (4.38%), State Street Corp (0.91%), Geode Capital Management LLC (0.82%), Raymond James Financial Services Advisors Inc. (0.28%) and Nuveen Asset Management LLC (0.24%). Company insiders that own Senseonics stock include Douglas A Roeder, Mukul Jain and Timothy T Goodnow. View institutional ownership trends for Senseonics.

SENS stock was sold by a variety of institutional investors in the last quarter, including NEA Management Company LLC, Morgan Stanley, UBS Group AG, BlackRock Inc., Spark Investment Management LLC, Raymond James Financial Services Advisors Inc., and Rhumbline Advisers. View insider buying and selling activity for Senseonics.

SENS stock was bought by a variety of institutional investors in the last quarter, including State Street Corp, Beacon Pointe Advisors LLC, Geode Capital Management LLC, Squarepoint Ops LLC, Alliancebernstein L.P., Advisor Group Holdings Inc., Wells Fargo & Company MN, and Palisades Hudson Asset Management L.P.. View insider buying and selling activity for Senseonics.

Shares of SENS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of SENS stock can currently be purchased for approximately $0.50.

Senseonics has a market capitalization of $111.97 million. Senseonics employs 191 workers across the globe.

The official website for Senseonics is www.senseonics.com.

Senseonics' mailing address is 20451 Seneca Meadows Pkwy, GERMANTOWN, MD 20876-7005, United States. The company can be reached via phone at +1-301-5157260.